 This is a study for patients with previously-treated advanced non-small cell lung cancer NSCLC. The study will evaluate the safety of adding an investigational drug, MK-3475 to standard treatment with gemcitabine. The study will also try to identify the best dose of MK-3475 to give in combination with gemcitabine. 